Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
Reports summarize angiogenesis study results from B. Bran and co-researchers
March 3rd, 2009
According to recent research from Mannheim, Germany, "Inhibition of angiogenesis by blocking angiogenic cytokines or their pathways has become a major target in experimental cancer therapies. This therapeutical approach requires a profound knowledge of growth factor profiles that contribute to tumor growth and progression." "The respective knowledge is presently rather incomplete for head and neck squamous cell carcinomas (HNSCC). Therefore we studied the serum levels and expression of platelet-derived growth factor (PDGF) in HNSCC patients and in cell Culture as well as the effect of a PDGF-receptor (PDGF-R) inhibition by Imatinib (Gleevec, ST1571) oil the secretion...
Source: Cancer Weekly (2009-03-03)
|
